We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OC icon
626
Owens Corning
OC
$11.2B
$1.97K ﹤0.01%
26
VIPS icon
627
Vipshop
VIPS
$7.3B
$1.97K ﹤0.01%
70
CERN
628
DELISTED
Cerner Corp
CERN
$1.96K ﹤0.01%
25
TJX icon
629
TJX Companies
TJX
$176B
$1.91K ﹤0.01%
28
LVS icon
630
Las Vegas Sands
LVS
$32.3B
$1.91K ﹤0.01%
32
+23
+256% +$1.23K
TRU icon
631
TransUnion
TRU
$15.4B
$1.89K ﹤0.01%
19
LTHM
632
DELISTED
Livent Corporation
LTHM
$1.85K ﹤0.01%
98
-4,542
-98% -$63.4K
AVLR
633
DELISTED
Avalara, Inc.
AVLR
$1.81K ﹤0.01%
+11
New +$1.76K
ORLY icon
634
O'Reilly Automotive
ORLY
$72.4B
$1.81K ﹤0.01%
60
EXPD icon
635
Expeditors International
EXPD
$21.8B
$1.81K ﹤0.01%
19
-5,758
-100% -$524K
UHS icon
636
Universal Health Services
UHS
$9.88B
$1.79K ﹤0.01%
13
CLGX
637
DELISTED
Corelogic, Inc.
CLGX
$1.78K ﹤0.01%
23
+3
+15% +$225
EWJ icon
638
iShares MSCI Japan ETF
EWJ
$22.1B
$1.76K ﹤0.01%
26
+4
+18% +$251
CHWY icon
639
Chewy
CHWY
$9.34B
$1.71K ﹤0.01%
+19
New +$1.39K
XLRN
640
DELISTED
Acceleron Pharma
XLRN
$1.66K ﹤0.01%
13
-967
-99% -$113K
HUM icon
641
Humana
HUM
$44B
$1.64K ﹤0.01%
4
BILI icon
642
Bilibili
BILI
$7.83B
$1.63K ﹤0.01%
19
-6,200
-100% -$363K
TSN icon
643
Tyson Foods
TSN
$21.4B
$1.61K ﹤0.01%
25
AUTL
644
Autolus Therapeutics
AUTL
$407M
$1.61K ﹤0.01%
180
EXPE icon
645
Expedia Group
EXPE
$35.2B
$1.59K ﹤0.01%
12
CAH icon
646
Cardinal Health
CAH
$53.2B
$1.55K ﹤0.01%
29
-21,237
-100% -$1.1M
RARE icon
647
Ultragenyx Pharmaceutical
RARE
$2.56B
$1.52K ﹤0.01%
11
GEN icon
648
Gen Digital
GEN
$16.3B
$1.48K ﹤0.01%
71
FLR icon
649
Fluor
FLR
$6.99B
$1.45K ﹤0.01%
91
CSX icon
650
CSX Corp
CSX
$93B
$1.45K ﹤0.01%
48

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.